Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Malar J. 2019 Jan 15;18(1):9. doi: 10.1186/s12936-019-2639-8.
Malaria can be transmitted by blood transfusion from human to human and it is responsible for the majority of transfusion-transmitted infectious diseases worldwide. In sub-Saharan Africa, it had been estimated that almost a quarter of blood donations contain malaria parasites. Since rapid diagnostic tests and thick blood smear microscopy lack sensitivity for low density parasitaemia, particularly in asymptomatic adults, the most reliable method to assess the problem of transfusion-transmitted malaria are nucleic acid-based molecular approaches such as quantitative polymerase chain reaction. The study was undertaken to determine the prevalence of sub-microscopic malaria parasite infection among blood donors in Malabo, Equatorial Guinea.
Between July and August 2017, a total of 200 individual blood samples from blood donors at the Malabo Blood Bank were collected and screened by rapid diagnostic tests and thick blood smear microscopy. Retrospectively, the same samples were analysed for the presence of undetected, low-density malaria parasites using quantitative polymerase chain reaction.
In comparison to 6.5% (13/200) by rapid diagnostic test and 2.0% (4/200) by microscopy, the proportion of Plasmodium falciparum positive blood donations analysed by quantitative polymerase chain reaction was significantly higher (26%, 52/200). Densities of P. falciparum positive blood donations were ranging from 0.06 to 3707.0 parasites/µL with 79.6% below 100 parasites/µL and therefore not detectable by non-molecular malaria diagnostic tests. qPCR based species identification revealed that P. falciparum was the dominating species responsible for 88.1% (52/59) of positive blood donations, followed by Plasmodium malariae (15.3%, 9/59) and Plasmodium ovale (3.4%, 2/59).
This study confirms that in malaria endemic settings, sub-patent malaria infections among blood donors are prevalent. In blood collected from healthy donors living in Malabo, P. falciparum, P. malariae and P. ovale parasites were identified. Currently widely used malaria diagnostic tools have missed more than 75% of P. falciparum containing blood donations, demonstrating the value of quantitative polymerase chain reaction to reliably detect low density P. falciparum infections. Since the availability of molecular diagnostic methods in malaria endemic countries is still limited, the blood recipients living in malaria endemic countries should be treated following WHO recommendations.
疟疾可通过人与人之间的输血传播,它是全球大多数输血传播传染病的罪魁祸首。在撒哈拉以南非洲,据估计,几乎四分之一的献血中含有疟原虫。由于快速诊断测试和厚血涂片显微镜检查对低密度寄生虫血症缺乏敏感性,特别是在无症状成人中,评估输血传播疟疾问题最可靠的方法是基于核酸的分子方法,如定量聚合酶链反应。本研究旨在确定赤道几内亚马拉博献血者中超微寄生虫感染的流行率。
2017 年 7 月至 8 月期间,从马拉博血库的 200 名献血者中采集并筛选了 200 份个体血样,分别采用快速诊断测试和厚血涂片显微镜检查进行检测。回顾性地,使用定量聚合酶链反应分析相同的样本是否存在未检测到的低密度疟原虫。
与快速诊断测试的 6.5%(13/200)和显微镜检查的 2.0%(4/200)相比,用定量聚合酶链反应分析的恶性疟原虫阳性献血者比例明显更高(26%,52/200)。恶性疟原虫阳性献血者的密度范围为 0.06 至 3707.0 个寄生虫/µL,其中 79.6%低于 100 个寄生虫/µL,因此无法通过非分子疟疾诊断检测到。基于 qPCR 的种属鉴定表明,恶性疟原虫是导致 52/59 份阳性献血者的主要种属,其次是间日疟原虫(15.3%,9/59)和卵形疟原虫(3.4%,2/59)。
本研究证实,在疟疾流行地区,献血者中存在亚临床疟疾感染。在从健康献血者采集的血液中,鉴定出恶性疟原虫、间日疟原虫和卵形疟原虫。目前广泛使用的疟疾诊断工具错过了超过 75%的含恶性疟原虫的献血,表明定量聚合酶链反应在可靠检测低密度恶性疟原虫感染方面具有价值。由于疟疾流行国家分子诊断方法的可用性仍然有限,生活在疟疾流行国家的血液接受者应按照世卫组织的建议进行治疗。